Title : Treatment of cutaneous T cell lymphoma: current status and future directions.

Pub. Date : 2002

PMID : 11978140






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Recent novel developments in CTCL therapy include oral bexarotene, a retinoid X receptor-selective retinoid that has activity in all stages of CTCL, and the topical gel formulation of bexarotene, which plays a role in treating localized lesions. Bexarotene TSPY like 2 Homo sapiens
2 Recent novel developments in CTCL therapy include oral bexarotene, a retinoid X receptor-selective retinoid that has activity in all stages of CTCL, and the topical gel formulation of bexarotene, which plays a role in treating localized lesions. Bexarotene TSPY like 2 Homo sapiens